Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age
Clinical trial NCT01711736 · COMPLETED
Trial details
- NCT number
- NCT01711736
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-02-21
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.